anmelden
OMX Nordic 40
2.686,85
PKT
-24,39
PKT
-0,90
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.02.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 25.02.19 | AstraZeneca overweight | Barclays Capital | |
| 25.02.19 | Nokia Outperform | Credit Suisse Group | |
| 25.02.19 | Nokia buy | UBS AG | |
| 20.02.19 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
| 18.02.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.02.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.02.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 12.02.19 | Volvo (B) Sell | UBS AG | |
| 11.02.19 | Novo Nordisk Reduce | HSBC | |
| 08.02.19 | Nokia buy | Deutsche Bank AG | |
| 06.02.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 05.02.19 | Volvo (B) buy | Jefferies & Company Inc. | |
| 05.02.19 | Novo Nordisk verkaufen | Barclays Capital | |
| 04.02.19 | Nokia overweight | Barclays Capital | |
| 04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 04.02.19 | Novo Nordisk Neutral | Credit Suisse Group | |
| 02.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 01.02.19 | Nokia buy | UBS AG | |
| 01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.19 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.02.19 | Nokia Outperform | Credit Suisse Group | |
| 31.01.19 | Volvo (B) buy | Kepler Cheuvreux | |
| 31.01.19 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 31.01.19 | Nokia overweight | JP Morgan Chase & Co. | |
| 31.01.19 | Nokia Outperform | Credit Suisse Group | |
| 31.01.19 | Nokia buy | UBS AG | |
| 30.01.19 | Volvo (B) Sell | UBS AG | |
| 30.01.19 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.19 | Nokia overweight | JP Morgan Chase & Co. | |
| 29.01.19 | Nokia Outperform | Credit Suisse Group | |
| 28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. |
